Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868604
Status:
RECRUITING
Last Update Posted:
2024-03-27
First Post:
2021-04-15
Brief Title:
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer SECuRE
Sponsor:
Clarity Pharmaceuticals Ltd
Organization:
Clarity Pharmaceuticals Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-15
First Submit QC Date:
April 27 2021
Study First Post Date:
2021-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-26
Last Update Post Date:
2024-03-27
Last Update Post Date Type:
ACTUAL